News

Archive: 27/08/2018

Booster partnership invests $10m in start ups

A “game-changing” new partnership between Viclink and New Zealand financial services company Booster, will see Booster invest at least $10 million in businesses spun out of the University’s world-leading research.   The...

Key to a cure?

Viclink spin-out company Avalia Immunotherapies[http://www.avaliaimmunotherapies.com/] could hold the key to a cure for chronic hepatitis B infection—a currently incurable, life-threatening liver disease that affects 250 million patients worldwide.   Avalia was formed...